Literature DB >> 30758790

Venous vessel wall thickness in lower extremity is increased in male patients with Behcet's disease.

Fatma Alibaz-Oner1, Rabia Ergelen2, Aydan Mutis3, Zeynep Erturk4, Ruslan Asadov2, Gonca Mumcu5, Tulin Ergun6, Haner Direskeneli4.   

Abstract

Vascular involvement, especially in young males, is seen in up to 40% of the patients with Behcet's disease (BD) and is a major cause of mortality and morbidity. In this study, we investigated vessel wall thickness (VWT) and dilatation in lower extremity veins with Doppler ultrasound (US) in male BD patients. Sixty-one male patients with BD, 37 healthy male controls (HC) and 27 male patients, with ankylosing spondylitis (AS), were included in the study. Venous Doppler US was performed by an experienced radiologist blinded to cases. Bilateral common femoral vein (CFV) wall thickness and great/small saphenous vein (SV) dilatations were assessed. All venous measurements were significantly higher in BD compared to AS and HC (p < 0.001 for all). Both right and left extremity CFV thicknesses had a high area under the ROC curve (> 0.8). Cut-off values for right and left CFV thicknesses for BD was 0.49 and 0.48 mm, respectively. High sensitivity and specificities are observed for both measurements (right CFV: sensitivity 81%, specificity 78.4%; left CFV: sensitivity 82.8%, specificity 81.1%). We found increased CFV thickness in BD patients independent of vascular involvement. As a similar change was not observed in controls, increased CFV thickness may be a specific sign of venous inflammation in BD. Our acceptable sensitivity and specificity values of CFV measurements suggest that assessment of femoral vein thickness with US may be a candidate diagnostic tool, especially in young males suspected of BD.

Entities:  

Keywords:  Behcet’s disease; Male; Venous wall thickness

Mesh:

Year:  2019        PMID: 30758790     DOI: 10.1007/s10067-019-04470-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

1.  Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis.

Authors:  Fatma Alibaz-Oner; Emrah Karatay; Ihsan Nuri Akpinar; Tulin Ergun; Haner Direskeneli
Journal:  Clin Rheumatol       Date:  2013-09-07       Impact factor: 2.980

2.  Magnetic resonance imaging of vein wall thickness in patients with Behçet's syndrome.

Authors:  Nicola Ambrose; Iain T Pierce; Peter D Gatehouse; Dorian O Haskard; David N Firmin
Journal:  Clin Exp Rheumatol       Date:  2014-09-30       Impact factor: 4.473

Review 3.  Major vessel involvement in Behçet's disease: an update.

Authors:  Kenneth T Calamia; Michael Schirmer; Melike Melikoglu
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

Review 4.  Behçet disease.

Authors:  H Yazici; S Yurdakul; V Hamuryudan
Journal:  Curr Opin Rheumatol       Date:  2001-01       Impact factor: 5.006

5.  Mortality in Behçet's disease.

Authors:  D Saadoun; B Wechsler; K Desseaux; D Le Thi Huong; Z Amoura; M Resche-Rigon; P Cacoub
Journal:  Arthritis Rheum       Date:  2010-09

6.  Patient-driven assessment of disease activity in Behçet's syndrome: cross-cultural adaptation, reliability and validity of the Turkish version of the Behçet's Syndrome Activity Score.

Authors:  Sedat Yilmaz; Ismail Simsek; Muhammet Cinar; Hakan Erdem; Osman Kose; Yusuf Yazici; Salih Pay
Journal:  Clin Exp Rheumatol       Date:  2013-09-09       Impact factor: 4.473

Review 7.  Subclinical atherosclerosis in Behcet's disease: A systematic review and meta-analysis.

Authors:  Mira Merashli; Irina Chis Ster; Paul Richard Julian Ames
Journal:  Semin Arthritis Rheum       Date:  2015-07-04       Impact factor: 5.532

8.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

9.  Birmingham Behçet's service: classification of disease and application of the 2014 International Criteria for Behçet's Disease (ICBD) to a UK cohort.

Authors:  Tim Blake; Luke Pickup; David Carruthers; Erika Marie Damato; Alastair Denniston; John Hamburger; Claire Maxton; Debbie Mitton; Philip I Murray; Peter Nightingale; Ana Poveda-Gallego; Andrea Richards; Andrew Whallett; Deva Situnayake
Journal:  BMC Musculoskelet Disord       Date:  2017-03-11       Impact factor: 2.362

10.  Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational study.

Authors:  Yohei Kirino; Haruko Ideguchi; Mitsuhiro Takeno; Akiko Suda; Kana Higashitani; Yosuke Kunishita; Kaoru Takase-Minegishi; Maasa Tamura; Toshiyuki Watanabe; Yukiko Asami; Takeaki Uehara; Ryusuke Yoshimi; Tetsu Yamazaki; Akiko Sekiguchi; Atsushi Ihata; Shigeru Ohno; Atsuhisa Ueda; Toshihisa Igarashi; Shohei Nagaoka; Yoshiaki Ishigatsubo; Hideaki Nakajima
Journal:  Arthritis Res Ther       Date:  2016-10-03       Impact factor: 5.156

  10 in total
  3 in total

Review 1.  Arterial and venous involvement in Behçet's syndrome: a narrative review.

Authors:  Neera Toledo-Samaniego; Crhistian Mario Oblitas; Eduardo Peñaloza-Martínez; Jorge Del-Toro-Cervera; Luis Antonio Alvarez-Sala-Walther; Pablo Demelo-Rodríguez; Francisco Galeano-Valle
Journal:  J Thromb Thrombolysis       Date:  2022-02-19       Impact factor: 2.300

2.  Neutrophil-mediated Thrombosis and NETosis in Behçet's Disease: a Hypothesis.

Authors:  Ezgi Deniz Batu
Journal:  J Korean Med Sci       Date:  2020-07-27       Impact factor: 2.153

3.  Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behçet's disease with symptoms or signs of vascular involvement: A cross-sectional study.

Authors:  Serdar Kaymaz; Halil Yilmaz; Furkan Ufuk; Ayşe Rüksan Ütebey; Veli Çobankara; Uğur Karasu; Canan Albayrak Yaşar; Firdevs Ulutaş
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.